Mediktor — Series A · €3M

Mediktor closed a €3M Series A led by Barcelona-based Alta Life Sciences through its Alta Life Sciences Spain I FCR fund, with Dutch investor Castel Capital and French skincare group NAOS (Bioderma) joining alongside existing business angels; English-language coverage quoted the round as $3.4M. The money was raised to commercialise its AI symptom-assessment app in North America, following the opening of its first US office in New York in May 2017.